-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Aquestive Therapeutics, Lowers Price Target to $8

Benzinga·03/07/2025 21:11:30
Listen to the news
Lake Street analyst Thomas Flaten maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and lowers the price target from $10 to $8.